Cenna Biosciences Inc.

San Diego, CA Doing business as Research And Development

UEI
RX54H8WFQGV5
CAGE
177RF, 4WT47
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
  • Woman Owned Business
  • Minority Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3405 Stadium Pl, San Diego, CA 92122, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cenna Biosciences Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Early clinical development of modified P8 for the treatment of alzheimer's disease - early clinical development of… Grant · R44AG087853 National Institute on Aging $2,675,000
Small molecule therapeutics for alzheimer's disease Grant · R44AG055182 National Institute on Aging $2,374,496
Small molecule therapeutics for alzheimer's disease Grant · R43AG055182 National Institutes of Health $225,000
Intranasal delivery of peptide drugs to the brain Grant · R43AG043278 National Institutes of Health $261,779
Intranasal delivery of peptide drugs to the brain Grant · R44AG043278 National Institute on Aging $9,979,215

Quick answers

What is Cenna Biosciences Inc.'s UEI?

Cenna Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is RX54H8WFQGV5.

What are Cenna Biosciences Inc.'s CAGE codes?

Cenna Biosciences Inc.'s CAGE codes are 177RF and 4WT47.

Where is Cenna Biosciences Inc. located?

Cenna Biosciences Inc.'s physical address in SAM.gov is 3405 Stadium Pl, San Diego, CA 92122, USA.

Is Cenna Biosciences Inc. registered in SAM.gov?

Yes. Cenna Biosciences Inc.'s SAM.gov registration is active through August 19, 2027.

What is Cenna Biosciences Inc.'s most recent federal award?

Cenna Biosciences Inc.'s most recent federal grant award is Early clinical development of modified P8 for the treatment of alzheimer's disease - early clinical development of… (R44AG087853), from National Institute on Aging, on September 20, 2024.

On GovTribe

See Cenna Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login